Osteoporosis Means Brittle Bones
Osteoporosis Means Brittle Bones
The hallmark of a condition we refer to as osteoporosis is characterized
by progressively weakened and brittle bones. Inadequate amounts
of calcium and phosphorous contribute to this debilitating condition.
Symptoms include back pain, stooped posture, and bone fractures. Between
the ages of 25 and 35, our peak bone mass is achieved. In the years
following, bone mass steadily decreases, particularly in women. Adequate
amounts of exercise, calcium, and vitamin D are essential for maintenance
of bone health.
Various prescription medications are available to decrease bone loss
and increase bone density over time. Bisphosphonate drugs, such as
alendronate (Fosamax) and risedronate (Actonel), work by inhibiting
bone breakdown, preserving bone mass, and increasing bone density.
Zoledronic acid (Reclast) is a bisphosphonate that is administered intravenously
once a year. Raloxifene (Evista) is a selective estrogen receptor
modulator, which provides advantages to bone density similar to those
of estrogen. Calcitonin (Miacalcin) is a synthetic hormone that works to
slow bone loss. Tamoxifen (Nolvadex) is also a synthetic hormone that
provides the benefits of estrogen on bone, and also helps reduce the risk
of breast cancer in women at high risk.